title: [Treatment tactics in giant cell tumor of the bone].
abstract: The data on 76 patients treated for benign or malignant giant-cell tumor (GCT) of the bone are presented. Surgery involving bone reconstruction and endoprosthetics was the basic therapeutic procedure. Cases with lytic benign GCT received 36-40 Gy of radiation prior to surgery whereas whose with malignant tumors were subjected to complex treatment including preoperative irradiation, surgery and chemotherapy. Recurrence was observed in two patients with benign and in one--with malignant GCT. There were four fatalities. Five-year survival was 82%.
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Lantsman
authors.forename: I I
authors.initials: II
authors.lastname: Anisenia
authors.forename: R A
authors.initials: RA
authors.lastname: Shagiakhmetova
authors.forename: L P
authors.initials: LP
authors.lastname: Vaks
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005870:Giant Cell Tumors / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D019736:Prostheses and Implants; D011879:Radiotherapy Dosage; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Lechebnaia taktika pri gigantokletochnykh opukholiakh kosteĭ.